NeuroFlex
PrivateLast Round
VC Round
Apr 13, 2022
Total Funding Raised
$10,000
Company Overview
NeuroFlex operates in Healthcare & Life Sciences and is based in Montreal. Its latest recorded funding round was a VC Round in April 2022.
NeuroFlex is a health technology company that has developed a virtual reality-based, eye-tracking platform designed for the evaluation of brain function.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, AR/VR Experiences, Healthcare Analytics, Sports & Fitness
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
NeuroFlex Comparables
Compare NeuroFlex with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| REACT Neuro | 90% | |
| NeuroSync | 89% | |
| RightEye | 81% |
For institutional investors. Book with your work email.
NeuroFlex Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Apr 13, 2022 | ||||
| Seed | Jun 12, 2019 | ||||
| Grant | Mar 30, 2017 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
NeuroFlex Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Powerhouse Ventures Limited | VC Round |
| Innovacorp | Seed |
| Powerhouse Ventures | VC Round |
| National Bank of Canada | Grant |
| MEDTEQ+ | Seed |
| McGill Dobson Centre for Entrepreneurship | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 30, 2017
$10K grant received from National Bank of Canada and McGill Dobson Centre.
For institutional investors. Book with your work email.
NeuroFlex Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about NeuroFlex's valuation, stock price, and market status.
Is NeuroFlex a public or private company?
NeuroFlex is a private company.
What is the current stock price of NeuroFlex?
NeuroFlex is a private company, so its shares have no public market price. Caplight tracks NeuroFlex's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is NeuroFlex worth (valuation)?
Valuation information for NeuroFlex is not publicly available.
Can I buy NeuroFlex stock?
NeuroFlex shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was NeuroFlex's last funding round?
NeuroFlex's most recent funding round was VC Round on April 13, 2022.
Who are the main investors in NeuroFlex?
Key investors in NeuroFlex include Powerhouse Ventures, MEDTEQ+.
Will NeuroFlex IPO soon?
No public IPO plans have been announced for NeuroFlex.
How can I track NeuroFlex secondary market activity?
Caplight tracks bids, offers, and trades in NeuroFlex's shares on secondary markets.